nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF2—mammary gland—lung cancer	0.0159	0.197	CbGeAlD
Pentosan Polysulfate—FGF1—mammary gland—lung cancer	0.0118	0.146	CbGeAlD
Pentosan Polysulfate—FGF2—bronchus—lung cancer	0.00873	0.108	CbGeAlD
Pentosan Polysulfate—FGF1—respiratory system—lung cancer	0.00789	0.0976	CbGeAlD
Pentosan Polysulfate—FGF2—trachea—lung cancer	0.00784	0.097	CbGeAlD
Pentosan Polysulfate—FGF1—epithelium—lung cancer	0.00659	0.0816	CbGeAlD
Pentosan Polysulfate—FGF2—lung—lung cancer	0.00563	0.0697	CbGeAlD
Pentosan Polysulfate—FGF1—cardiac atrium—lung cancer	0.00548	0.0678	CbGeAlD
Pentosan Polysulfate—FGF1—lung—lung cancer	0.00419	0.0518	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—lung cancer	0.00385	0.0477	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—lung cancer	0.00286	0.0354	CbGeAlD
Pentosan Polysulfate—Dizziness—Erlotinib—lung cancer	0.000389	0.00111	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Paclitaxel—lung cancer	0.000389	0.00111	CcSEcCtD
Pentosan Polysulfate—Anaemia—Paclitaxel—lung cancer	0.000388	0.0011	CcSEcCtD
Pentosan Polysulfate—Malaise—Etoposide—lung cancer	0.000386	0.0011	CcSEcCtD
Pentosan Polysulfate—Agitation—Paclitaxel—lung cancer	0.000385	0.00109	CcSEcCtD
Pentosan Polysulfate—Headache—Vinblastine—lung cancer	0.000384	0.00109	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Etoposide—lung cancer	0.000383	0.00109	CcSEcCtD
Pentosan Polysulfate—Oedema—Cisplatin—lung cancer	0.000381	0.00108	CcSEcCtD
Pentosan Polysulfate—Insomnia—Irinotecan—lung cancer	0.000379	0.00108	CcSEcCtD
Pentosan Polysulfate—Infection—Cisplatin—lung cancer	0.000378	0.00108	CcSEcCtD
Pentosan Polysulfate—Vomiting—Topotecan—lung cancer	0.000378	0.00107	CcSEcCtD
Pentosan Polysulfate—Malaise—Paclitaxel—lung cancer	0.000378	0.00107	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Irinotecan—lung cancer	0.000377	0.00107	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Paclitaxel—lung cancer	0.000375	0.00107	CcSEcCtD
Pentosan Polysulfate—Rash—Topotecan—lung cancer	0.000375	0.00107	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Vinorelbine—lung cancer	0.000375	0.00106	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Topotecan—lung cancer	0.000375	0.00106	CcSEcCtD
Pentosan Polysulfate—Vomiting—Erlotinib—lung cancer	0.000374	0.00106	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Irinotecan—lung cancer	0.000374	0.00106	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Cisplatin—lung cancer	0.000373	0.00106	CcSEcCtD
Pentosan Polysulfate—Headache—Topotecan—lung cancer	0.000373	0.00106	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000372	0.00106	CcSEcCtD
Pentosan Polysulfate—Rash—Erlotinib—lung cancer	0.000371	0.00105	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Erlotinib—lung cancer	0.000371	0.00105	CcSEcCtD
Pentosan Polysulfate—Insomnia—Gemcitabine—lung cancer	0.00037	0.00105	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Irinotecan—lung cancer	0.000369	0.00105	CcSEcCtD
Pentosan Polysulfate—Headache—Erlotinib—lung cancer	0.000369	0.00105	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Cisplatin—lung cancer	0.000368	0.00105	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Gemcitabine—lung cancer	0.000367	0.00104	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Irinotecan—lung cancer	0.000365	0.00104	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Gemcitabine—lung cancer	0.000364	0.00104	CcSEcCtD
Pentosan Polysulfate—Nausea—Vinblastine—lung cancer	0.000364	0.00103	CcSEcCtD
Pentosan Polysulfate—Anorexia—Cisplatin—lung cancer	0.000363	0.00103	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—lung cancer	0.000363	0.00103	CcSEcCtD
Pentosan Polysulfate—Alopecia—Docetaxel—lung cancer	0.000361	0.00102	CcSEcCtD
Pentosan Polysulfate—Pruritus—Vinorelbine—lung cancer	0.00036	0.00102	CcSEcCtD
Pentosan Polysulfate—Discomfort—Etoposide—lung cancer	0.00036	0.00102	CcSEcCtD
Pentosan Polysulfate—Constipation—Irinotecan—lung cancer	0.000359	0.00102	CcSEcCtD
Pentosan Polysulfate—Myalgia—Paclitaxel—lung cancer	0.000357	0.00101	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Paclitaxel—lung cancer	0.000357	0.00101	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Gemcitabine—lung cancer	0.000355	0.00101	CcSEcCtD
Pentosan Polysulfate—Nausea—Topotecan—lung cancer	0.000353	0.001	CcSEcCtD
Pentosan Polysulfate—Discomfort—Paclitaxel—lung cancer	0.000353	0.001	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—lung cancer	0.000352	0.001	CcSEcCtD
Pentosan Polysulfate—Constipation—Gemcitabine—lung cancer	0.00035	0.000993	CcSEcCtD
Pentosan Polysulfate—Nausea—Erlotinib—lung cancer	0.00035	0.000993	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—lung cancer	0.000349	0.000991	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vinorelbine—lung cancer	0.000348	0.000989	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000347	0.000986	CcSEcCtD
Pentosan Polysulfate—Infection—Etoposide—lung cancer	0.000347	0.000985	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Irinotecan—lung cancer	0.000346	0.000982	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Irinotecan—lung cancer	0.000343	0.000975	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—lung cancer	0.000343	0.000973	CcSEcCtD
Pentosan Polysulfate—Oedema—Paclitaxel—lung cancer	0.000342	0.000972	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Cisplatin—lung cancer	0.000342	0.000972	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Etoposide—lung cancer	0.000342	0.000971	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—lung cancer	0.00034	0.000966	CcSEcCtD
Pentosan Polysulfate—Infection—Paclitaxel—lung cancer	0.00034	0.000966	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Cisplatin—lung cancer	0.00034	0.000965	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Etoposide—lung cancer	0.000337	0.000959	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Gemcitabine—lung cancer	0.000337	0.000957	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vinorelbine—lung cancer	0.000336	0.000956	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—lung cancer	0.000336	0.000953	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Paclitaxel—lung cancer	0.000335	0.000952	CcSEcCtD
Pentosan Polysulfate—Anorexia—Etoposide—lung cancer	0.000333	0.000945	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Irinotecan—lung cancer	0.000332	0.000942	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Cisplatin—lung cancer	0.000331	0.000941	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Paclitaxel—lung cancer	0.000331	0.00094	CcSEcCtD
Pentosan Polysulfate—Anaemia—Docetaxel—lung cancer	0.000328	0.000933	CcSEcCtD
Pentosan Polysulfate—Depression—Methotrexate—lung cancer	0.000327	0.000929	CcSEcCtD
Pentosan Polysulfate—Anorexia—Paclitaxel—lung cancer	0.000326	0.000927	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—lung cancer	0.000326	0.000926	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vinorelbine—lung cancer	0.000323	0.000919	CcSEcCtD
Pentosan Polysulfate—Rash—Vinorelbine—lung cancer	0.000321	0.000911	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vinorelbine—lung cancer	0.00032	0.00091	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Methotrexate—lung cancer	0.000319	0.000908	CcSEcCtD
Pentosan Polysulfate—Headache—Vinorelbine—lung cancer	0.000319	0.000905	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—lung cancer	0.000319	0.000905	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Docetaxel—lung cancer	0.000318	0.000904	CcSEcCtD
Pentosan Polysulfate—Sweating—Methotrexate—lung cancer	0.000314	0.000893	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Cisplatin—lung cancer	0.000314	0.000892	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Etoposide—lung cancer	0.000313	0.00089	CcSEcCtD
Pentosan Polysulfate—Haematuria—Methotrexate—lung cancer	0.000313	0.000888	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000312	0.000886	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Etoposide—lung cancer	0.000311	0.000884	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—lung cancer	0.00031	0.000881	CcSEcCtD
Pentosan Polysulfate—Insomnia—Paclitaxel—lung cancer	0.00031	0.000879	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Methotrexate—lung cancer	0.000309	0.000878	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Irinotecan—lung cancer	0.000309	0.000878	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Paclitaxel—lung cancer	0.000307	0.000873	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Paclitaxel—lung cancer	0.000305	0.000867	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Etoposide—lung cancer	0.000303	0.000862	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Docetaxel—lung cancer	0.000303	0.00086	CcSEcCtD
Pentosan Polysulfate—Myalgia—Docetaxel—lung cancer	0.000303	0.00086	CcSEcCtD
Pentosan Polysulfate—Nausea—Vinorelbine—lung cancer	0.000302	0.000859	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Paclitaxel—lung cancer	0.000301	0.000856	CcSEcCtD
Pentosan Polysulfate—Constipation—Etoposide—lung cancer	0.000298	0.000848	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Paclitaxel—lung cancer	0.000297	0.000845	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—lung cancer	0.000294	0.000835	CcSEcCtD
Pentosan Polysulfate—Constipation—Paclitaxel—lung cancer	0.000293	0.000831	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Methotrexate—lung cancer	0.000292	0.00083	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—lung cancer	0.000291	0.000825	CcSEcCtD
Pentosan Polysulfate—Oedema—Docetaxel—lung cancer	0.00029	0.000824	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—lung cancer	0.00029	0.000823	CcSEcCtD
Pentosan Polysulfate—Pruritus—Gemcitabine—lung cancer	0.000289	0.000822	CcSEcCtD
Pentosan Polysulfate—Infection—Docetaxel—lung cancer	0.000288	0.000819	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—lung cancer	0.000288	0.000818	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Etoposide—lung cancer	0.000288	0.000817	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Irinotecan—lung cancer	0.000287	0.000816	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Etoposide—lung cancer	0.000285	0.000811	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Docetaxel—lung cancer	0.000284	0.000807	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Paclitaxel—lung cancer	0.000282	0.000801	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Cisplatin—lung cancer	0.000281	0.000797	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Paclitaxel—lung cancer	0.00028	0.000795	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Gemcitabine—lung cancer	0.00028	0.000794	CcSEcCtD
Pentosan Polysulfate—Dizziness—Irinotecan—lung cancer	0.000277	0.000788	CcSEcCtD
Pentosan Polysulfate—Urticaria—Etoposide—lung cancer	0.000277	0.000788	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—lung cancer	0.000277	0.000786	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—lung cancer	0.000277	0.000786	CcSEcCtD
Pentosan Polysulfate—Anorexia—Docetaxel—lung cancer	0.000276	0.000785	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Etoposide—lung cancer	0.000276	0.000784	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—lung cancer	0.000276	0.000784	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—lung cancer	0.000274	0.000779	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—lung cancer	0.000272	0.000773	CcSEcCtD
Pentosan Polysulfate—Urticaria—Paclitaxel—lung cancer	0.000272	0.000772	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—lung cancer	0.000271	0.000769	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Paclitaxel—lung cancer	0.000271	0.000769	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—lung cancer	0.000268	0.000761	CcSEcCtD
Pentosan Polysulfate—Vomiting—Irinotecan—lung cancer	0.000267	0.000758	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—lung cancer	0.000266	0.000756	CcSEcCtD
Pentosan Polysulfate—Rash—Irinotecan—lung cancer	0.000265	0.000752	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Irinotecan—lung cancer	0.000264	0.000751	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000264	0.000751	CcSEcCtD
Pentosan Polysulfate—Headache—Irinotecan—lung cancer	0.000263	0.000747	CcSEcCtD
Pentosan Polysulfate—Insomnia—Docetaxel—lung cancer	0.000262	0.000745	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Cisplatin—lung cancer	0.000261	0.000741	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Docetaxel—lung cancer	0.00026	0.00074	CcSEcCtD
Pentosan Polysulfate—Alopecia—Methotrexate—lung cancer	0.00026	0.000739	CcSEcCtD
Pentosan Polysulfate—Vomiting—Gemcitabine—lung cancer	0.00026	0.000738	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Docetaxel—lung cancer	0.000259	0.000735	CcSEcCtD
Pentosan Polysulfate—Rash—Gemcitabine—lung cancer	0.000258	0.000732	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Gemcitabine—lung cancer	0.000257	0.000731	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Etoposide—lung cancer	0.000257	0.000731	CcSEcCtD
Pentosan Polysulfate—Headache—Gemcitabine—lung cancer	0.000256	0.000727	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—lung cancer	0.000255	0.000726	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Docetaxel—lung cancer	0.000255	0.000725	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—lung cancer	0.000253	0.000718	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Docetaxel—lung cancer	0.000252	0.000716	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Paclitaxel—lung cancer	0.000252	0.000716	CcSEcCtD
Pentosan Polysulfate—Nausea—Irinotecan—lung cancer	0.000249	0.000708	CcSEcCtD
Pentosan Polysulfate—Constipation—Docetaxel—lung cancer	0.000248	0.000705	CcSEcCtD
Pentosan Polysulfate—Pruritus—Etoposide—lung cancer	0.000247	0.000702	CcSEcCtD
Pentosan Polysulfate—Nausea—Gemcitabine—lung cancer	0.000243	0.00069	CcSEcCtD
Pentosan Polysulfate—Vomiting—Cisplatin—lung cancer	0.000242	0.000688	CcSEcCtD
Pentosan Polysulfate—Pruritus—Paclitaxel—lung cancer	0.000242	0.000688	CcSEcCtD
Pentosan Polysulfate—Rash—Cisplatin—lung cancer	0.00024	0.000682	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Cisplatin—lung cancer	0.00024	0.000682	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Docetaxel—lung cancer	0.000239	0.000679	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Etoposide—lung cancer	0.000239	0.000678	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—lung cancer	0.000238	0.000675	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—lung cancer	0.000238	0.000675	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Docetaxel—lung cancer	0.000237	0.000674	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—lung cancer	0.000237	0.000673	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Paclitaxel—lung cancer	0.000234	0.000665	CcSEcCtD
Pentosan Polysulfate—Malaise—Methotrexate—lung cancer	0.000231	0.000656	CcSEcCtD
Pentosan Polysulfate—Dizziness—Etoposide—lung cancer	0.000231	0.000656	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Docetaxel—lung cancer	0.000229	0.000651	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Methotrexate—lung cancer	0.000229	0.000651	CcSEcCtD
Pentosan Polysulfate—Dizziness—Paclitaxel—lung cancer	0.000226	0.000643	CcSEcCtD
Pentosan Polysulfate—Nausea—Cisplatin—lung cancer	0.000226	0.000643	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—lung cancer	0.000225	0.00064	CcSEcCtD
Pentosan Polysulfate—Vomiting—Etoposide—lung cancer	0.000222	0.00063	CcSEcCtD
Pentosan Polysulfate—Rash—Etoposide—lung cancer	0.00022	0.000625	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Etoposide—lung cancer	0.00022	0.000625	CcSEcCtD
Pentosan Polysulfate—Headache—Etoposide—lung cancer	0.000219	0.000621	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—lung cancer	0.000219	0.000621	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—lung cancer	0.000218	0.00062	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—lung cancer	0.000218	0.00062	CcSEcCtD
Pentosan Polysulfate—Vomiting—Paclitaxel—lung cancer	0.000218	0.000618	CcSEcCtD
Pentosan Polysulfate—Rash—Paclitaxel—lung cancer	0.000216	0.000613	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Paclitaxel—lung cancer	0.000216	0.000612	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—lung cancer	0.000215	0.000612	CcSEcCtD
Pentosan Polysulfate—Headache—Paclitaxel—lung cancer	0.000214	0.000609	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Docetaxel—lung cancer	0.000214	0.000607	CcSEcCtD
Pentosan Polysulfate—Infection—Methotrexate—lung cancer	0.000208	0.00059	CcSEcCtD
Pentosan Polysulfate—Nausea—Etoposide—lung cancer	0.000207	0.000589	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—lung cancer	0.000206	0.000585	CcSEcCtD
Pentosan Polysulfate—Pruritus—Docetaxel—lung cancer	0.000205	0.000583	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—lung cancer	0.000205	0.000582	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—lung cancer	0.000205	0.000582	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—lung cancer	0.000204	0.000579	CcSEcCtD
Pentosan Polysulfate—Nausea—Paclitaxel—lung cancer	0.000203	0.000577	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—lung cancer	0.000202	0.000574	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—lung cancer	0.0002	0.000568	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—lung cancer	0.000199	0.000566	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—lung cancer	0.000199	0.000564	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Docetaxel—lung cancer	0.000198	0.000564	CcSEcCtD
Pentosan Polysulfate—Dizziness—Docetaxel—lung cancer	0.000192	0.000545	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00019	0.000541	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—lung cancer	0.000189	0.000537	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—lung cancer	0.000189	0.000536	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—lung cancer	0.000189	0.000536	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—lung cancer	0.000188	0.000533	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—lung cancer	0.000187	0.00053	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—lung cancer	0.000186	0.000529	CcSEcCtD
Pentosan Polysulfate—Vomiting—Docetaxel—lung cancer	0.000184	0.000524	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—lung cancer	0.000184	0.000523	CcSEcCtD
Pentosan Polysulfate—Rash—Docetaxel—lung cancer	0.000183	0.00052	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Docetaxel—lung cancer	0.000183	0.000519	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—lung cancer	0.000182	0.000516	CcSEcCtD
Pentosan Polysulfate—Headache—Docetaxel—lung cancer	0.000182	0.000516	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—lung cancer	0.000181	0.000514	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—lung cancer	0.00018	0.000511	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—lung cancer	0.000177	0.000504	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—lung cancer	0.000175	0.000497	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—lung cancer	0.000173	0.00049	CcSEcCtD
Pentosan Polysulfate—Nausea—Docetaxel—lung cancer	0.000172	0.000489	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—lung cancer	0.000172	0.000489	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—lung cancer	0.000171	0.000486	CcSEcCtD
Pentosan Polysulfate—Urticaria—Methotrexate—lung cancer	0.000166	0.000472	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—lung cancer	0.000165	0.000469	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000165	0.000469	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—lung cancer	0.000164	0.000465	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—lung cancer	0.000163	0.000462	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—lung cancer	0.000161	0.000458	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—lung cancer	0.000159	0.000453	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—lung cancer	0.000157	0.000447	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—lung cancer	0.000155	0.00044	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—lung cancer	0.000154	0.000438	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—lung cancer	0.000149	0.000424	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—lung cancer	0.000148	0.000421	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—lung cancer	0.000148	0.00042	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—lung cancer	0.000144	0.000409	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—lung cancer	0.000143	0.000407	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methotrexate—lung cancer	0.000143	0.000406	CcSEcCtD
Pentosan Polysulfate—Dizziness—Methotrexate—lung cancer	0.000138	0.000393	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—lung cancer	0.000133	0.000379	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methotrexate—lung cancer	0.000133	0.000378	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—lung cancer	0.000132	0.000374	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—lung cancer	0.000132	0.000374	CcSEcCtD
Pentosan Polysulfate—Headache—Methotrexate—lung cancer	0.000131	0.000372	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—lung cancer	0.000128	0.000364	CcSEcCtD
Pentosan Polysulfate—Nausea—Methotrexate—lung cancer	0.000124	0.000353	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—lung cancer	0.000124	0.000352	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—lung cancer	0.00012	0.00034	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—lung cancer	0.000115	0.000327	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—lung cancer	0.000114	0.000324	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—lung cancer	0.000114	0.000324	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—lung cancer	0.000113	0.000322	CcSEcCtD
Pentosan Polysulfate—Nausea—Doxorubicin—lung cancer	0.000108	0.000305	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—IL6R—lung cancer	2.54e-05	4.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CREBBP—lung cancer	2.54e-05	4.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AVP—lung cancer	2.53e-05	4.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—lung cancer	2.53e-05	4.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KIT—lung cancer	2.53e-05	4.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APC—lung cancer	2.53e-05	4.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDH1—lung cancer	2.52e-05	4.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—lung cancer	2.52e-05	4.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGF—lung cancer	2.5e-05	4.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MAPK3—lung cancer	2.47e-05	4.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAP2K1—lung cancer	2.45e-05	4.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1R—lung cancer	2.44e-05	4.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CD—lung cancer	2.44e-05	4.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—lung cancer	2.43e-05	4.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAP2K1—lung cancer	2.42e-05	4.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MDM2—lung cancer	2.41e-05	4.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—lung cancer	2.41e-05	4.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CD—lung cancer	2.41e-05	4.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—lung cancer	2.4e-05	4.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB3—lung cancer	2.4e-05	4.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—lung cancer	2.4e-05	4.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RAF1—lung cancer	2.4e-05	4.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HES1—lung cancer	2.4e-05	4.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—lung cancer	2.39e-05	4.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—BRAF—lung cancer	2.37e-05	4.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB2—lung cancer	2.37e-05	4.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MDM2—lung cancer	2.36e-05	4.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—RAF1—lung cancer	2.35e-05	4.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—lung cancer	2.35e-05	4.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6R—lung cancer	2.35e-05	4.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CREBBP—lung cancer	2.34e-05	4.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CB—lung cancer	2.34e-05	4.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MTOR—lung cancer	2.34e-05	4.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB2—lung cancer	2.33e-05	4.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—lung cancer	2.31e-05	4.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—lung cancer	2.3e-05	4.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MTOR—lung cancer	2.3e-05	4.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CB—lung cancer	2.3e-05	4.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—lung cancer	2.3e-05	4.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD4—lung cancer	2.29e-05	4.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—lung cancer	2.29e-05	4.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—lung cancer	2.25e-05	3.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGFR1—lung cancer	2.24e-05	3.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAP2K1—lung cancer	2.24e-05	3.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—lung cancer	2.23e-05	3.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CD—lung cancer	2.22e-05	3.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—lung cancer	2.22e-05	3.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—lung cancer	2.21e-05	3.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIF1A—lung cancer	2.2e-05	3.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—lung cancer	2.2e-05	3.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—lung cancer	2.19e-05	3.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB3—lung cancer	2.19e-05	3.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MDM2—lung cancer	2.18e-05	3.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—RAF1—lung cancer	2.17e-05	3.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MDM2—lung cancer	2.15e-05	3.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—lung cancer	2.15e-05	3.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—lung cancer	2.15e-05	3.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—lung cancer	2.15e-05	3.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RAF1—lung cancer	2.15e-05	3.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—lung cancer	2.14e-05	3.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—lung cancer	2.13e-05	3.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOA1—lung cancer	2.12e-05	3.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—lung cancer	2.12e-05	3.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTOR—lung cancer	2.12e-05	3.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CB—lung cancer	2.12e-05	3.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CD4—lung cancer	2.12e-05	3.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—lung cancer	2.11e-05	3.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—lung cancer	2.11e-05	3.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—lung cancer	2.11e-05	3.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—lung cancer	2.1e-05	3.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—lung cancer	2.1e-05	3.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—lung cancer	2.1e-05	3.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MTOR—lung cancer	2.1e-05	3.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CB—lung cancer	2.1e-05	3.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD4—lung cancer	2.09e-05	3.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JUN—lung cancer	2.09e-05	3.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JUN—lung cancer	2.05e-05	3.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—lung cancer	2.04e-05	3.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGFR1—lung cancer	2.04e-05	3.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—lung cancer	2.04e-05	3.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—lung cancer	2.04e-05	3.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—lung cancer	2.03e-05	3.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—lung cancer	2.03e-05	3.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1A—lung cancer	2.03e-05	3.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—lung cancer	2.02e-05	3.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIF1A—lung cancer	2.01e-05	3.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1A—lung cancer	1.99e-05	3.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MDM2—lung cancer	1.99e-05	3.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—lung cancer	1.99e-05	3.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—RAF1—lung cancer	1.98e-05	3.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—lung cancer	1.97e-05	3.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—lung cancer	1.96e-05	3.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—lung cancer	1.96e-05	3.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—lung cancer	1.95e-05	3.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—lung cancer	1.94e-05	3.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CG—lung cancer	1.94e-05	3.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APC—lung cancer	1.94e-05	3.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIT—lung cancer	1.94e-05	3.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOA1—lung cancer	1.94e-05	3.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTOR—lung cancer	1.94e-05	3.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CB—lung cancer	1.94e-05	3.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CD4—lung cancer	1.93e-05	3.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EP300—lung cancer	1.93e-05	3.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—lung cancer	1.93e-05	3.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—lung cancer	1.92e-05	3.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—lung cancer	1.92e-05	3.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGF—lung cancer	1.92e-05	3.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EP300—lung cancer	1.89e-05	3.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—lung cancer	1.89e-05	3.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—lung cancer	1.89e-05	3.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SRC—lung cancer	1.88e-05	3.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JUN—lung cancer	1.87e-05	3.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—POMC—lung cancer	1.85e-05	3.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SRC—lung cancer	1.84e-05	3.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1A—lung cancer	1.84e-05	3.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—lung cancer	1.83e-05	3.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—lung cancer	1.83e-05	3.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—lung cancer	1.82e-05	3.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1A—lung cancer	1.82e-05	3.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—lung cancer	1.81e-05	3.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STAT3—lung cancer	1.81e-05	3.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRAS—lung cancer	1.81e-05	3.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—lung cancer	1.81e-05	3.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—lung cancer	1.8e-05	3.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6R—lung cancer	1.8e-05	3.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CREBBP—lung cancer	1.8e-05	3.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—lung cancer	1.79e-05	3.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STAT3—lung cancer	1.78e-05	3.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRAS—lung cancer	1.77e-05	3.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APC—lung cancer	1.77e-05	3.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIT—lung cancer	1.77e-05	3.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CG—lung cancer	1.77e-05	3.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EP300—lung cancer	1.75e-05	3.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGF—lung cancer	1.75e-05	3.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK3—lung cancer	1.73e-05	3.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EP300—lung cancer	1.73e-05	3.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—lung cancer	1.72e-05	3.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAP2K1—lung cancer	1.72e-05	3.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CD—lung cancer	1.71e-05	3.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SRC—lung cancer	1.7e-05	3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK3—lung cancer	1.7e-05	2.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—POMC—lung cancer	1.68e-05	2.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—lung cancer	1.68e-05	2.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SRC—lung cancer	1.68e-05	2.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1A—lung cancer	1.68e-05	2.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—lung cancer	1.67e-05	2.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—lung cancer	1.67e-05	2.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—lung cancer	1.66e-05	2.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—lung cancer	1.64e-05	2.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6R—lung cancer	1.64e-05	2.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STAT3—lung cancer	1.64e-05	2.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CREBBP—lung cancer	1.64e-05	2.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRAS—lung cancer	1.64e-05	2.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STAT3—lung cancer	1.62e-05	2.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRAS—lung cancer	1.62e-05	2.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—lung cancer	1.61e-05	2.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EP300—lung cancer	1.6e-05	2.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK3—lung cancer	1.57e-05	2.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAP2K1—lung cancer	1.57e-05	2.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CD—lung cancer	1.56e-05	2.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—lung cancer	1.55e-05	2.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SRC—lung cancer	1.55e-05	2.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK3—lung cancer	1.55e-05	2.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MDM2—lung cancer	1.53e-05	2.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—lung cancer	1.53e-05	2.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—lung cancer	1.52e-05	2.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RAF1—lung cancer	1.52e-05	2.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—lung cancer	1.51e-05	2.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STAT3—lung cancer	1.5e-05	2.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRAS—lung cancer	1.49e-05	2.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—lung cancer	1.49e-05	2.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MTOR—lung cancer	1.49e-05	2.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CB—lung cancer	1.49e-05	2.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—lung cancer	1.47e-05	2.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK3—lung cancer	1.43e-05	2.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—lung cancer	1.43e-05	2.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—lung cancer	1.43e-05	2.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—lung cancer	1.41e-05	2.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—lung cancer	1.4e-05	2.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MDM2—lung cancer	1.39e-05	2.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—lung cancer	1.39e-05	2.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—lung cancer	1.39e-05	2.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RAF1—lung cancer	1.39e-05	2.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—lung cancer	1.38e-05	2.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—lung cancer	1.37e-05	2.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—lung cancer	1.37e-05	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—lung cancer	1.37e-05	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—lung cancer	1.36e-05	2.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CB—lung cancer	1.36e-05	2.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MTOR—lung cancer	1.36e-05	2.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—lung cancer	1.33e-05	2.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUN—lung cancer	1.33e-05	2.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—lung cancer	1.32e-05	2.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—lung cancer	1.3e-05	2.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—lung cancer	1.3e-05	2.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—lung cancer	1.29e-05	2.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—lung cancer	1.29e-05	2.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1A—lung cancer	1.29e-05	2.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—lung cancer	1.28e-05	2.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—lung cancer	1.28e-05	2.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—lung cancer	1.28e-05	2.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—lung cancer	1.26e-05	2.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—lung cancer	1.25e-05	2.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—lung cancer	1.24e-05	2.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—lung cancer	1.24e-05	2.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EP300—lung cancer	1.22e-05	2.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—lung cancer	1.21e-05	2.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUN—lung cancer	1.21e-05	2.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—lung cancer	1.2e-05	2.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SRC—lung cancer	1.19e-05	2.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—lung cancer	1.18e-05	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—lung cancer	1.18e-05	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—lung cancer	1.18e-05	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1A—lung cancer	1.17e-05	2.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—lung cancer	1.17e-05	2.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—lung cancer	1.17e-05	2.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—lung cancer	1.16e-05	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT3—lung cancer	1.15e-05	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRAS—lung cancer	1.15e-05	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—lung cancer	1.15e-05	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—lung cancer	1.14e-05	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—lung cancer	1.13e-05	2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EP300—lung cancer	1.12e-05	1.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK3—lung cancer	1.1e-05	1.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—lung cancer	1.09e-05	1.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SRC—lung cancer	1.09e-05	1.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—lung cancer	1.07e-05	1.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—lung cancer	1.06e-05	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—lung cancer	1.06e-05	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT3—lung cancer	1.05e-05	1.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRAS—lung cancer	1.04e-05	1.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—lung cancer	1.04e-05	1.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—lung cancer	1.04e-05	1.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—lung cancer	1.04e-05	1.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK3—lung cancer	1e-05	1.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—lung cancer	9.86e-06	1.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—lung cancer	9.73e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—lung cancer	9.64e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—lung cancer	9.52e-06	1.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—lung cancer	9.06e-06	1.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—lung cancer	8.99e-06	1.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—lung cancer	8.77e-06	1.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—lung cancer	8.38e-06	1.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—lung cancer	8.26e-06	1.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—lung cancer	8.02e-06	1.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—lung cancer	7.99e-06	1.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—lung cancer	7.64e-06	1.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—lung cancer	7.4e-06	1.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—lung cancer	7.32e-06	1.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—lung cancer	6.75e-06	1.19e-05	CbGpPWpGaD
